News About: Pharm. Industry
Robust 2002 sales seen in foreign-invested pharmaceutical firms
Despite initial perspective that the domestic pharmaceutical industry would suffer a serious setback in its projected turnover and growth last year, the majority of foreign-invested pharmaceutical firms fared well in ...
Domestic drug companies to keep hot eyes on Amaryl market.
The domestic pharmaceutical companies are keenly interests in the Amaryl (glymepiride: a anti-diabetic drug) market since the patent protection already expired in Korea and its post market surveillance (PMS) also ende...
Share of larger wholesalers with combined turnover of more than 100 billion won up
The statistics compiled by the Tax Union shows that with the share of larger wholesalers increasing, the combined turnover of domestic wholesalers has been surging on a year-on-year; 2.1602 trillion won in 2000, 2.938...
Domestic pharmaceutical industry faces murky economic outlook
Market analysts said that confronted with the increasing dismal outlook, a number of pharmaceutical firms have reportedly failed to achieve their sales target in the first quarter of this year due to sluggish sales in...
Dongshin Pharm and Wyeth Korea to seek strategic alliance
Dongshin Pharm said on April 1 that it made a co-marketing arrangement with Wyeth Korea for the following ten items: Varidase tab. (anti-inflammatory enzyme preparation), Minocin cap. (oral antibiotic), Ozex tab. (ora...
M. Richter named new KRPIA chairman
The Korea Research-based Pharmaceutical Industry Association announced on April 1 that it appointed M. Richter, president of Boehringer Ingelheim Korea, as the 6th chairman (See "yakup@yakup.com" dated March 26, 2003)...
Korea Green Cross signs deal to buy Daishin Life Insurance
The Korea Green Cross will be a new owner of the troubled Daishin Life Insurance as Korea Deposit Insurance Corp. (KDIC) passed its sell-off plan to select the KGC in its committee meeting on March 26.
The KGC said...
Roche's Ansung plant acquires EU GMP certification
Roche Korea said recently that its Ansung plant succeeded in obtaining EU GMP certification from the Swedish Medical Products Agency on February 21 this year, as a result of the agency's on-spot inspection headed by D...
LG and Canadian Aeterna to agree business strategic tie-up for anticancer drug.
LG and Canadian Aeterna to agree business strategic tie-up for anticancer drug.
LG made a strategic business cooperation agreement with Canadian Aeterna company on Mar. 26 for an exclusive distribution of Neovasta...
Yuyu made strategic tie-up with Pharmacia.
Yuyu agreed with Pharmacia on Mar. 27 to take over Lincocin, an excellent antibiotic and Mycobutin, a anti-TB drug via the import, distribution, product registration rights, trademarks and technical know-how.
Linc...
